Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when
administered by itself (without any other anti-epileptic medication) to epilepsy patients for
the treatment of partial seizures. This is an extension study to a previous clinical trial.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.